Home » Pharma Packaging

Pharma Packaging

Related Pages

There is no doubt about the fact that pharmaceuticals packaging or pharma packaging occupies a very important place in the packaging industry. A recent report has shown that the demand for worldwide drug packaging has shown a growth of 5.3 per cent annually and has reached $24.3 billion (€20 7 billion) in 2009. In future the adoption of stricter regulations and standards governing the production, storage, distribution and labellings of pharmaceuticals will boost global growth opportunities for packaging products and accessories.

The European Medicines Agency (EMEA) decision to update guidelines on the use of plastic packaging in pharmaceuticals is one example of efforts to improve standards within the industry. The EMEA chose to update its 1994 guidelines on the use of plastic primary packaging materials in light of the Common Technical Document, which came into force on 1 July 2003.

Types of Pharma Packaging

Send online enquiry for pharma packaging supplies, pharma packaging products, pharma packaging materials, blister packaging, anti counter counterfeit packaging etc. Get the best response from genuine packaging manufacturers and suppliers. Click here to send your enquiry.

Pharmaceutical Packaging Regulations
Regulations to govern pharmaceutical packaging not only focus on preserving the quality of enclosed medication but the emerging threat of product tampering and counterfeiting means policy must now take a international perspective. These requirements are now being extended additionally to cover such criteria the assurance of product dispensing accuracy and the promotion of patient compliance with product dosage schedules.

Segment-wise, packaging of solid oral ethical and over-the-counter drugs show sustained growth as they are distributed in large quantities to institutional and retail pharmacies. Along with this, pharmaceutical pouches and strip packs generate average growth, while medication tubes provide much softer growth potential. In the area of parenteral packaging, pre-fillable syringes fare the best in the marketplace due to advantages in infection prevention and in emergency response times.

Pharma Packaging Market
The US is the largest consumer of pharmaceutical packaging. It is likely to remain so as the country's advanced proprietary drug producing sector introduces new sophisticated preparations with specialized storage requirements. China is expected to register the fastest growth in demand based on rapidly expanding pharmaceutical manufacturing capabilities and the phasing-in of a government-mandated program to upgrade the quality of nationally produced medicines.
Currently, pre-fillable inhalers show great promise over other primary containers as new asthma and allergy medicines with specialized administration requirements reach the market. The market for glass pharmaceutical bottles and jars witness a downturn as applications are lost to blister packs and high barrier plastic bottles, studies suggest.

Pharmaceutical packaging occupies around 10 to 15 per cent of the overall drugs and pharmaceutical market and is growing steadily with the same pace of the industry. Of this, blister packaging has the lead with a 60 per cent share of the primary packaging market. Primary packaging comes to around 60 per cent of the total packaging industry.
pharmaceutical packaging

Also, the upbeat trend in the pharma industry also has opened up considerable opportunities to the packaging machinery development both on the packaging line operations and end of line operations. Packaging is already considered an essential aspect of the product in the regulated markets. Though they are yet to form stringent regulations, the developed world is now seriously getting aware of the fact that packaging is an important aspect.